RDIF

Russia Is Struggling To Make Sputnik V Doses. Why?

Making Sense of the Spat Between Anvisa and Gamaleya Over Sputnik V Vaccines

Data Shows India May Not Have Enough Doses To Meet Its COVID Vaccination Targets

India Readies for 600M Vaccine Doses, To Use Standard Cold Storage: Govt Expert

Dr Reddy’s, RDIF Begin Clinical Trials for Sputnik V Vaccine in India

Pharma Firm Hetero to Produce Russia’s Sputnik V COVID-19 Vaccine in India